A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.
Mol Ther
; 23(1): 192-201, 2015 Jan.
Article
in En
| MEDLINE
| ID: mdl-25322757
Full text:
1
Database:
MEDLINE
Main subject:
Genetic Therapy
/
Dystrophin
/
Muscular Dystrophy, Duchenne
/
Follistatin-Related Proteins
/
Myostatin
Limits:
Adult
/
Humans
/
Male
Language:
En
Year:
2015
Type:
Article